Regeneron
Trade Regeneron 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.
REGN Key Statistics
Stock Snapshot
As of today, Regeneron(REGN) shares are valued at $783.71. The company's market cap stands at 82.37B, with a P/E ratio of 18.76 and a dividend yield of 44.9%.
On 2025-12-26, Regeneron(REGN) stock traded between a low of $783.61 and a high of $792.77. Shares are currently priced at $783.71, which is +0.0% above the low and -1.1% below the high.
The Regeneron(REGN)'s current trading volume is 259.87K, compared to an average daily volume of 968.17K.
In the last year, Regeneron(REGN) shares hit a 52-week high of $792.77 and a 52-week low of $476.49.
In the last year, Regeneron(REGN) shares hit a 52-week high of $792.77 and a 52-week low of $476.49.
REGN News
Below is Validea's guru fundamental report for REGENERON PHARMACEUTICALS INC (REGN). Of the 22 guru strategies we follow, REGN rates highest using our Value Inv...
Regeneron (REGN) and Sanofi (SNY) announced that the Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for D...
(RTTNews) - Sanofi (SNY, SAN.PA) said The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent or...
Analyst ratings
67%
of 30 ratingsMore REGN News
Alvotech (ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical (TEVA) announced that they have reached a settlement and license agreement wit...